| Current Price | $88.87 | Mkt Cap | $180.7B |
|---|---|---|---|
| Open | $88.71 | P/E Ratio | 22.98 |
| Prev. Close | $80.49 | Div. (Yield) | $2.08 (2.3%) |
| Daily Range | $88.71 - $89.08 | Volume | 778,385 |
| 52-Wk Range | $77.04 - $98.52 | Avg. Daily Vol. | 1,878,355 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
| Current Price | $88.87 | Mkt Cap | $180.7B |
|---|---|---|---|
| Open | $88.71 | P/E Ratio | 22.98 |
| Prev. Close | $80.49 | Div. (Yield) | $2.08 (2.3%) |
| Daily Range | $88.71 - $89.08 | Volume | 778,385 |
| 52-Wk Range | $77.04 - $98.52 | Avg. Daily Vol. | 1,878,355 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
TMFacarchidi
(< 20)
Submitted: 8/14/2020 12:06:04 PM :
Start Price:
$85.01
NYSE:NVS Score:
-18.26
It's the most flexible and versatile of the large pharma companies, and its leadership places tremendous value on scientific effectiveness as well as managerial competence.
Recs
jbswen
(< 20)
Submitted: 3/27/2020 2:10:51 PM :
Start Price:
$79.17
NYSE:NVS Score:
-49.45
With this epidemic and once the find a cure they are for sure to take off
Recs
XMFmarkprvulovic
(< 20)
Submitted: 10/17/2019 4:21:14 AM :
Start Price:
$82.06
NYSE:NVS Score:
-34.58
Growing revenues among most major drugs, with its top therapy seeing an impressive 23% increase in quarterly revenue. Updated clinical results for breast cancer drug are also highly impressive.
Find the members with the highest scoring picks in NVS.
wcwhiner (27.65) Score: +185.98
The Score Leader is the player with the highest score across all their picks in NVS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Bankwatcher1 | 22.49 | 10/7/2008 |
|
NS | $38.28 | +132.31% | +302.84% | +170.54 | 0 Comment | |
| Spelunkin | 23.97 | 11/2/2009 |
|
5Y | $38.67 | +129.98% | +298.35% | +168.37 | 0 Comment | |
| wcwhiner | 27.65 | 4/28/2009 |
|
NS | $27.73 | +220.74% | +387.45% | +166.71 | 0 Comment | |
| PurePwnage | 98.45 | 11/27/2009 |
|
5Y | $41.02 | +116.83% | +282.66% | +165.83 | 0 Comment | |
| TrackDuality | < 20 | 11/6/2009 |
|
5Y | $39.09 | +127.52% | +290.36% | +162.85 | 0 Comment | |
| 39272x0 | 26.04 | 12/2/2009 |
|
5Y | $42.06 | +111.44% | +272.75% | +161.32 | 0 Comment | |
| kaChingkaChing | 33.24 | 12/2/2009 |
|
3W | $42.06 | +111.44% | +272.75% | +161.32 | 0 Comment | |
| BridgeTech | < 20 | 5/29/2009 |
|
3Y | $29.84 | +198.02% | +358.49% | +160.46 | 0 Comment | |
| DiamondDawg | 88.81 | 11/25/2009 |
|
5Y | $41.69 | +113.33% | +273.12% | +159.79 | 0 Comment | |
| 39272x4 | < 20 | 11/10/2009 |
|
5Y | $39.99 | +122.38% | +279.47% | +157.10 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
